| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $381.1M | +74.5% |
| Cost of Revenue | $233.5M | +44.8% |
| Gross Profit | $147.6M | +158.2% |
| R&D Expense | $31.0M | +74.4% |
| SG&A Expense | $58.0M | +66.0% |
| Operating Income | -$74.1M | -26.2% |
| Interest Expense | $4.4M | +418.5% |
| Pre-tax Income | -$76.0M | -23.8% |
| Income Tax | $36K |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $65.7M | -23.9% |
| Short-term Investments | $253.8M | +733.0% |
| Accounts Receivable | $49.2M | +51.7% |
| Inventory | $1.6M | -22.7% |
| Current Assets | $390.1M | +138.7% |
| Total Assets | $736.9M | +46.6% |
| Current Liabilities | $63.8M | +11.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62.6M | +8.7% |
| Capital Expenditures | $13.7M | +118.0% |
| Investing Cash Flow | -$238.6M | -12.2% |
| Financing Cash Flow | $281.0M | -8.7% |
| Free Cash Flow | -$76.2M | -1.9% |
| — |
| Net Income | -$76.0M | -23.9% |
| EPS (Basic) | -$1.61 | +30.9% |
| EPS (Diluted) | -$1.61 | +30.9% |
| Total Liabilities |
| $362.1M |
| +369.6% |
| Stockholders' Equity | $373.7M | -11.9% |